Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study

OBJECTIVE: Intraperitoneal (IP) chemotherapy in women with optimally debulked stage III ovarian cancer has been reported to prolong overall survival, but has not been widely adopted due to concerns about its toxicity, inconvenience and acceptability to patients. The purposes of this study were to de...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Blinman, Prunella, Gainford, Corona, Donoghoe, Mark, Martyn, Julie, Blomfield, Penny, Grant, Peter, Kichenadasse, Ganessan, Vaughan, Michelle, Brand, Alison, Shannon, Catherine, Gebski, Val, Stockler, Martin, Friedlander, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3805917/
https://ncbi.nlm.nih.gov/pubmed/24167672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2013.24.4.359
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak